LENALID 5MG CAPSULE(lenalidomide )- apple pharmaceuticals

-

LENALID 5MG CAPSULE(lenalidomide )- apple pharmaceuticals


  • The indications of Lenalid 5mg are; Lenalid ( lenalidomide) combination with dexamethasone is indicated to treat the patients suffered from multiple myeloma, the main ingredient which is used as Lenalidomide . 
  • Lenalid 5mg capsule is indicated for the patients having transfusion-dependent anemia because of intermediate 1 risk myelodysplastic syndrome along with deletion 5q cytogenetic abnormality without or without addition cytogenetic abnormalities Lenalid ( Lenalidomide) is used to treat the patients with mantle cell lymphoma in which its used whose the disease was relapsed or progressed after two before treatment, especially the disease not response with the bortezomib therapy.
Lenalid 5mg , Lenalid 5mg capsule

MECHANISM

  • Lenalid 5mg involves in the prudence of tumor and factor alpha arrangement, thatreinforcement the T-cells and leads to lessening plasma levels of cytokines vascular endothelial growth factor and fundamental fibroblast growth factor. Lenalid 5mg capsule is moreover engaged with the stave off angiogenesis. Lenalidomide is furthermoreauthorize G1 cell cycle capture and apoptosis of ruinous cells.
  • The adult usual dose of Lenalid( Lenalidomide) 5mg in myelodysplastic syndromes is 10mg and adminisrated once a day. For renal damaged patients; CrCl>60ml/minIn Patients should not needed dosage adjustment of Lenalid CrCl 30 to 60ml/minIn Patients, 5mg of Lenalid( lenalidomide) should administre orally as once daily CrCl<30ml/minIn Patient, 2.5mg of Lenalid 5mg capsule should be given orally as a once daily. Dosage variation;

Thrombocytopenia:

  • Drops to <50000/mcL, treatment should be interrupted. Back to > or equal to 50000/mcL, follow the Lenalid 5mg capsule per day.

Neutropenia;

  • Drops to <500/mcL, treatment should be delayed. Back to > or equal to 500/mcL, treatment should be follow to 5mg per day.

Multiple myeloma

  • In this disease, concomitant use of dexamethasone with Lenalid 5mg. The regular dose of Lenalid( lenalidomide) is 25mg should be given as once in a day on day 1 to 21. The dose of dexamethasone; Dexamethasone 40mg should be continued on day 1 to 4, 9 to 12 & 17 to 20 of each period of28-day cycles. Patient with greater than 75 years, dexamethasone20mg should be prescribed on day 1, 8, 15, & 22.

PHARMACOKINETICS

Absorption:

  • absorbed rapidly withpeak plasma concentration is between 0.625 and 1.5 hrs. combining with food will not change the prolong of absorption but dose decrease in Cmax.

Distribution:

  • bounding of plasma protein is 30%

Metabolism:

  • mainly metabolized in two metabolites is hydroxy-lenalidomide and N-acetyl-lenalidomide.

Excretion:

  • primarily eliminated in renal route and the dose excreted via urine 90% and feces 4% and half-life is 3hrs

MANTLE CELL LYMPHOMA

Mantle cell lymphoma

  • The usual dose of Lenalid( Lenalidomide) for this disease is 25mg should be given orally as once daily. For renal damaged patients; CrCl 30 to 60ml/min in patient, Lenalid 5mg should be given as once daily. CrCl<30ml/min in patients, Lenalid( lenalidomide) 15mg should be used for q48hr. Pediatrics; The safety&efficiency of Lenalidomide has not been decribed in pediatric patients with age of <18 years.

DRUG INTERACTION

  • Interaction of Lenalid 5mg capsule with digoxin leads to increased concentration of digoxin causes increased risk of adverse effects related to digoxin. Interaction of Lenalid 5mg with Erythropoietic agents, cause to produced rises in risk of thrombosis. Discuss with the patients prior to starting this combination treatment. Interaction of Lenalid( lenalidomide) 5mgwith warfarin, will produce increased exposure of hemorrhage disorders. check the INR value & prothrombin time.

OVER DOSAGE

  • Over dosage of Lenalid 5mg will cause neutropenia& thrombocytopenia as mainly common side effects. Give the patient general supportive treatment. check the blood cells counts regularily during the treatment.

MISSED DOSE

  • The missed dose of Lenalid 5mg capsule should be avoided. If missed dose founded, then patients should be consulting with doctor specialized in oncologist Regulate theusual dosing schedule.

CONTRAINDICATION

  • When pregnancy period the drug is contraindicated The patients are contraindicated to hypersensitivity reaction and the Lenalid 5mg component.
Lenalid 5mg , Lenalid 5mg capsule

SIDE EFFECTS

  • Second primary malignancies Hepatotoxicity , Hypersensitivity reactions, Thyroid dysfunction, Fetal toxicity, Hematological toxicity, Tumor lysis syndrome, Tumor flare reactions, Increase of mortality rate.

Common side effects;

  • Diabetes mellitus, Rash, Insomnia, Depression, Deep vein thrombosis, Myocardial infraction, Renal failure, Squamous cell carcinoma, Basal cell carcinoma, Fatigue, Asthenia, Pyrexia, Pain, Diarrhea, Dyspepsia, Bone pain, Neck pain, Respiratory infections, UTI, Influenza, Sepsis, Headache, Anemia, Loss of appetite, Hypokalemia, Hyperglycemia, Hypocalcaemia, Dehydration, Gout.

WARNING

The some of the common life-threatening condition like

  • Venous & arterial thromboembolism
  • Blood clotting effects
  • Embryo fetal damage
  • Hypersensitivity reactions
  • Hematological disorders
  • For all these conditions, some supportive measures should be used and provide safety measures.

CONTACT DETAILS

Comments

Post a Comment

Popular posts from this blog

Scapho 150mg Inyección (NOVARTIS)

-
Image
Scapho 150mg Secukinumab 150mg pertenece al anticuerpo monoclonal que es una proteína que reconoce y se conecta a una proteína inflamatoria llamada Interleukin 17A (IL-17A). En pacientes con artritis psoriásica y espondilitis anquilosante, el sistema inmunitario del cuerpo produce una mayor cantidad de IL-17A que causa síntomas como inflamación y dolor en las articulaciones. Scapho 150mg es un medicamento recetado que se usa bajo la guía adecuada de un oncólogo médico. Scapho 150mg injection INDICACIÓN Scapho 150mg indicado para el tratamiento de la siguiente afección Placa de psoriasis Artritis psoriásica Espondilitis anquilosante. DOSIFICACIÓN Psoriasis en placas: Dosis inicial: administrada 300 mg SC en las semanas 0,1, 2, 3 y 4 inicialmente en la semana 8, administrar 300 mg SC una vez al mes Para algunos pacientes puede ser aceptable que contenga una dosis de 150 mg Artritis psoriásica: Indicada para adultos con artritis psoriásica activa. ...
Read more

MABALL - 500MG(Anti Cancer Drug)

-
Image
MABALL - 500MG(Anti Cancer Drug) DESCRIPTION Maball 500mg  is a anticancer medicine which prevents the growth and spread of cancer cells in the body, the main ingredient which is used as.  Maball   will help to prevent the Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment.  Maball 500mg  with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. Maball 500mg injection INDICATION Maball 500mg  and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC).  Maball 500mg injection  combination with methotrexate (Otrexup, Rasuvo, Xatmep, others) is also indicated for the treatme...
Read more

REDITUX - 500MG(ANTI CANCER DRUG)

-
Image
REDITUX - 500MG(ANTI CANCER DRUG) DESCRIPTION: Reditux 500mg is a anticancer medicine which prevents the growth and spread of cancer cells in the body. Reditux   will help to prevent the Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment. Reditux 500mg with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. Reditux 500mg injection INDICATION Reditux 500mg and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC). Reditux 500mg injection combination with methotrexate (Otrexup, Rasuvo, Xatmep, others) is also indicated for the treatment rheumatoid arthritis symptoms in adults that have been already treated...
Read more